The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide

被引:114
作者
Brantley-Finley, C
Lyle, CS
Du, LH
Goodwin, ME
Hall, T
Szwedo, D
Kaushal, GP
Chambers, TC [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA
关键词
JNK; ERK; p53; vinblastine; doxorubicin; etoposide; apoptosis;
D O I
10.1016/S0006-2952(03)00255-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Assessment of specific apoptosis and survival pathways implicated in anticancer drug action is important for understanding drug mechanisms and modes of resistance in order to improve the benefits of chemotherapy. In order to better examine the role of mitogen-activated protein kinases, including JNK and ERK, as well as the tumor suppressor p53, in the response of tumor cells to chemotherapy, we compared the effects on these pathways of three structurally and functionally distinct antitumor agents. Drug concentrations equal to 50 times the concentration required to reduce cell proliferation by 50% were used. Vinblastine, doxorubicin, or etoposide (VP-16) induced apoptotic cell death in KB-3 carcinoma cells, with similar kinetic profiles of PARP cleavage, caspase 3 activation, and mitochondrial cytochrome c release. All three drugs strongly activated JNK, but only vinblastine induced c-Jun phosphorylation and AP-1 activation. Inhibition of JNK by SP600125 protected cells from drug-induced cytotoxicity. Vinblastine caused inactivation of ERK whereas ERK was unaffected in cells exposed to doxorubicin or VP-16. Inhibition of ERK signaling by the MEK inhibitor, U0126, potentiated the cytotoxic effects of vinblastine and doxorubicin, but not that of VP-16. Vinblastine induced p53 downregulation, and chemical inhibition of p53 potentiated vinblastine-induced cell death, suggesting a protective effect of p53. In contrast, doxorubicin and VP-16 induced p53. and inhibition of p53 decreased drug-induced cell death, suggesting a pro-apoptotic role for p53. These results highlight the differential roles played by several key signal transduction pathways in the mechanisms of action of key antitumor agents, and suggest ways to specifically potentiate their effects in a context- dependent manner. In addition, the novel finding that JNK activation can occur without c-Jun phosphorylation or AP-1 activation has important implications for our understanding of JNK function. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:459 / 469
页数:11
相关论文
共 32 条
[1]   Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress [J].
Amundson, SA ;
Myers, TG ;
Fornace, AJ .
ONCOGENE, 1998, 17 (25) :3287-3299
[2]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[3]   AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells [J].
Berry, A ;
Goodwin, M ;
Moran, CL ;
Chambers, TC .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (05) :581-591
[4]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[5]   Mitochondrion as a novel target of anticancer chemotherapy [J].
Costantini, P ;
Jacotot, E ;
Decaudin, D ;
Kroemer, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13) :1042-1053
[6]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[7]  
Dent P, 2001, CLIN CANCER RES, V7, P775
[8]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[9]   Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy [J].
Fan, MY ;
Chambers, TC .
DRUG RESISTANCE UPDATES, 2001, 4 (04) :253-267
[10]  
Fan MY, 2001, CANCER RES, V61, P4450